| Fondsname | Alta Life Sciences Spain I FCR |
|---|---|
| Registrierungsnummer CNMV | 203 |
| ISIN | ES0108631005 |
| First Closing | September 2016 |
| Final Closing | Dezember 2019 |
| Fondsvolumen | 79 Mio. € |
| Investmentstrategie | Strategie: Investments in Biotechnology, Biopharma, Medical Devices / Diagnostics, Genomics and Digital Health Segment: All development stages: Seed, Series A, Series B y Series C,D,E… geografische Ausrichtung: Mainly Spain Art des Deals: Direct investments, along with companies management teams |
